Dishman Signs API Development Deal with Polish Firm

Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it has signed a cooperation and joint active pharmaceutical ingredient (API) development agreement with Polpharma (Starogard GdaƄski, Poland), a manufacturer of APIs and finished dosage forms. Polpharma is a strong player in its home market and a leader in the Central and Eastern European markets and Commonwealth of Independent States (CIS) countries, says Dishman, a custom manufacturer of APIs and drug intermediates. “Such partnerships will ensure long-term API manufacturing contracts to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers